CRVS holders · CITADEL ADVISORS LLC 13F · CRVS stock
CITADEL ADVISORS LLC Corvus Pharmaceuticals Inc (CRVS) 13F holding
CITADEL ADVISORS LLC reported 442,522 CRVS shares valued at $6.5M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest CRVS 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the CRVS holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 442,522 | $6.5M | COM |
| 2025-12-31 | 208,182 | $1.6M | COM |
| 2025-09-30 | 42,766 | $315.2K | COM |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.